An ensemble predictive modeling framework for breast cancer classification.

Area of Science:

• Bioinformatics
• Computational Biology
• Genomics

Background:

• Molecular changes can precede disease clinical presentation, serving as valuable surrogates for clinical decision-making.
• Classification models predicting clinical outcomes from molecular expression profiles are increasingly utilized.
• Traditional methods often use all molecular markers, leading to high-dimensional, sparse data that can be challenging for analysis.

Purpose of the Study:

• To develop and evaluate a novel ensemble classification approach for predicting good and poor-prognosis breast cancer samples.
• To enhance the accuracy of clinical outcome prediction from molecular expression data.
• To address limitations of traditional classification methods in high-dimensional genomic datasets.

Main Methods:

• A variant of an ensemble classification approach was employed.
• Multiple base classifiers with varying feature sets, derived from 2D sample projections, were used with a majority voting strategy.
• Base classifiers were selected based on maximal sensitivity and minimal redundancy (low average cosine distance).
• Ensemble sets were modeled as undirected graphs.

Main Results:

• The proposed ensemble framework demonstrated superior performance compared to traditional single classifier systems for four different classification algorithms.
• The study identified a subset of genes with high-degree centrality in network abstractions, specifically within poor-prognosis samples.
• The ensemble method effectively predicted breast cancer prognosis from molecular expression profiles.

Conclusions:

• The developed ensemble classification approach offers improved accuracy for predicting breast cancer prognosis.
• Network analysis of gene expression data can reveal significant molecular markers associated with disease prognosis.
• This method provides a robust framework for leveraging molecular data in clinical decision-making for breast cancer.